These results, together with a former report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 help the strategy of focusing on ACKR3 as a novel solution to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Problems. By ticking this box https://seingalg405dvc5.get-blogging.com/profile